https://www.nature.com/articles/d41586-023-02528-2
0
0
8/10/23 at 8:07pm
Organization
Nature.com
33 words
0
Comments
Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashes risk of heart attacks and other cardiovascular incidents.
You are the first to view
Create an account
or login to join the discussion